Traditional Chinese medicine composition for treating viral myocarditis

Abstract

The invention relates to a traditional Chinese medicine composition for treating viral myocarditis. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-30 parts of radix codonopsis, 5-25 parts of schisandra chinensis, 5-20 parts of rhizome arisaematis, 5-25 parts of cassia twig, 5-25 parts of auricularia auricula, 5-25 parts of tuber fleeceflower stem, 5-20 parts of hematoxylon, 5-25 parts of herba cistanches, 5-25 parts of tribulus terrestris, 5-25 parts of rhizoma polygoni cuspidati, 5-25 parts of semen ziziphi spinosae, 5-20 parts of cassia seed, 5-25 parts of lily, 5-25 parts of isatis root, 5-25 parts of copperleaf herb, 5-25 parts of fingered citron, 5-20 parts of radix pseudostellariae, 5-25 parts of rhizoma polygonati, 5-25 parts of herba aristolochiae, 5-20 parts of crotalaria ferruginea, 5-25 parts of herba rabdosiae, 5-25 parts of prepared radix rehmanniae, 5-25 parts of loquat leaves, 5-25 parts of oenanthe rosthornii and 5-15 parts of radix liquiritiae. The traditional Chinese medicine composition has the efficacies of benefiting qi, nourishing blood, moisturizing lung by nourishing yin, clearing away heat and toxic materials, promoting qi circulation to relieve pain, activating blood, removing blood stasis and tranquilizing by nourishing the heart and is remarkable in curative effect of treating the viral myocarditis and reliable in effect.

Description

technical field [0001] The invention relates to a medicinal preparation of an undetermined structure of a traditional herbal medicine, in particular to a traditional Chinese medicine composition for treating viral myocarditis. Background technique [0002] Viral myocarditis is a localized or diffuse acute, subacute or chronic inflammatory cardiomyopathy associated with viral infection, and is the most common infectious myocarditis. Mostly children and adults under the age of 40. Among them, 35% of patients are between the ages of 10-30, and the age of onset in adults is mostly between 31-35 years old. About 90% of the patients complain of arrhythmia as the main complaint or the first symptoms. Palpitations, chest tightness, precordial pain, dizziness, fatigue and other symptoms are common. , easy to merge with cardiogenic shock or lead to cardiomyopathy. At present, there is no effective treatment in Western medicine, and immunosuppressants, interferon and cardiomyocyte n...

AI Technical Summary

Problems solved by technology

At present, there is no effective treatment in western medicine, and immunosuppressants, interferon and cardiomyocyte nutrition are often used in clinic for symptomatic treatment. Although they have certain curative effects, they have the disadvantages of treating the symptoms but not the root cause and side effects